These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8937249)

  • 21. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketoconazole in the treatment of antimony- and pentamidine-resistant kala-azar.
    Wali JP; Aggarwal P; Gupta U; Saluja S; Singh S
    J Infect Dis; 1992 Jul; 166(1):215-6. PubMed ID: 1607703
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of kala-azar in India.
    Thakur CP
    Natl Med J India; 1992; 5(5):203-5. PubMed ID: 1338871
    [No Abstract]   [Full Text] [Related]  

  • 24. Availability of miltefosine for the treatment of kala-azar in India.
    Sundar S; Murray HW
    Bull World Health Organ; 2005 May; 83(5):394-5. PubMed ID: 15976883
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of miltefosine in treatment of post-kala-azar dermal leishmaniasis.
    Sundar S; Singh A; Chakravarty J; Rai M
    ScientificWorldJournal; 2015; 2015():414378. PubMed ID: 25685839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
    Thakur CP; Kumar A; Mitra G; Thakur S; Sinha PK; Das P; Bhattacharya SK; Sinha A
    Indian J Med Res; 2008 Jul; 128(1):38-44. PubMed ID: 18820357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. India makes good progress in combating kala-azar.
    Cousins S
    Lancet; 2015 May; 385(9979):1716. PubMed ID: 25943925
    [No Abstract]   [Full Text] [Related]  

  • 29. Indian kala-azar--better tools needed for diagnosis and treatment.
    Sundar S
    J Postgrad Med; 2003; 49(1):29-30. PubMed ID: 12865568
    [No Abstract]   [Full Text] [Related]  

  • 30. The efficacy and safety of ketoconazole in visceral leishmaniasis.
    Rashid JR; Wasunna KM; Gachihi GS; Nyakundi PM; Mbugua J; Kirigi G
    East Afr Med J; 1994 Jun; 71(6):392-5. PubMed ID: 7835263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and management of Kala azar.
    Singh UK
    Indian Pediatr; 1999 Mar; 36(3):231-6. PubMed ID: 10713835
    [No Abstract]   [Full Text] [Related]  

  • 32. The treatment of kala-azar: old and new options.
    Zijlstra EE
    Trop Geogr Med; 1992 Jul; 44(3):288. PubMed ID: 1455546
    [No Abstract]   [Full Text] [Related]  

  • 33. PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh.
    Salam MA; Mondal D; Kabir M; Ekram AR; Haque R
    Acta Trop; 2010 Jan; 113(1):52-5. PubMed ID: 19769932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case report of Kala-Azar in a kidney transplant patient.
    Malek Hosseini SA; Javid R; Salahi H; Nezakatgoo N; Ahmad E; Ghahramani N
    Transplant Proc; 1995 Oct; 27(5):2715. PubMed ID: 7482886
    [No Abstract]   [Full Text] [Related]  

  • 35. [Kala-azar in pregnant women].
    Massip P; Goutner C; Dupic Y; Navarrot P
    Presse Med; 1986 May; 15(20):933. PubMed ID: 2940581
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of sodium antimony gluconate and ketoconazole in the treatment of kala-azar--a comparative study.
    Wali JP; Aggarwal P; Nandy A; Singh S; Addy M; Guha SK; Dwivedi SN; Karmarkar MG; Maji AK
    J Commun Dis; 1997 Jun; 29(2):73-83. PubMed ID: 9282505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visceral leishmaniasis (kala-azar) in bone marrow aspirate.
    Economopoulos T; Giannopoulos G; Raptis S
    Eur J Haematol; 2002 Jun; 68(6):400. PubMed ID: 12225401
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
    Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD
    Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Kala-azar. Apropos of a case report in a Belgian woman].
    Coutellier P; Delgrange B
    Acta Clin Belg; 1989; 44(5):362-3. PubMed ID: 2609847
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemotherapy of antimonial compounds in kala-azar infection. Part IV. Further observations on the therapeutic values of urea stibamine. By U.N. Brahmachari, 1922.
    Brahmachari UN
    Indian J Med Res; 1989 Jan; 89():393-404. PubMed ID: 2644171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.